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A B S T R A C T
Background: Human biomonitoring studies have demonstrated decreasing concentrations of many persistent
organic pollutants (POPs) in years after emission peaks.
Objectives: To describe time trends of POPs in blood using four cross-sectional samples of 30 year olds from
Tromsø, Norway across 1986–2007, and to compare the measured concentrations of polychlorinated biphenyl
153 (PCB-153) to model-estimated values. A second objective was to compare the repeated cross-sectional time
trends with those observed in our previous longitudinal study using repeated individual measurements in older
men from the same surveys.
Methods: Serum from 45 persons aged 30 years in each of the following years: 1986, 1994, 2001, and 2007 was
analyzed for 14 POPs. Further, predicted concentrations of PCB-153 in each sampling year were derived using
the emission-based CoZMoMAN model.
Results: The median decreases in summed serum POP concentrations (lipid-adjusted) in 1994, 2001, and 2007
relative to 1986 were − 71%, − 81%, and − 86% for women and − 65%, − 77%, and − 87% for men, re-
spectively. The overall time trend in predicted PCB-153 concentrations demonstrated agreement with the ob-
served trend although model predictions were higher than the measured concentrations at all time points.
Compared to our previous longitudinal study of repeated individual measurements in older men, similar al-
though more prominent declines were observed in the younger cross-sectional samples.
Discussion: Observed declines in serum concentrations from 1986 to 2007 were substantial for legacy POPs in
men and women at reproductive ages in Northern Norway and are generally consistent with previous long-
itudinal biomonitoring efforts in the study population. The measured concentrations and observed declines
likely reflect a combination of recent and historic exposures. Small differences in time trends observed between
the studies could be attributed to different study designs (i.e. the chosen age group or sex and cross-sectional
versus repeated individual measurement sampling).
1. Introduction
Biomonitoring of persistent organic pollutants (POPs) in humans
has demonstrated decreasing concentrations of POPs for which historic
production and use have been restricted or banned in national and
international efforts. For example, concentrations of polychlorinated
biphenyls (PCBs) and many organochlorine pesticides have decreased
in human blood in many ‘western countries’ since the 1980s (Hagmar
et al., 2006; Hovinga et al., 1992; Høyer et al., 2000; Tee et al., 2003;
Vo et al., 2008). In our previous longitudinal study of five repeated
individual measurements of serum POP concentrations in 53 men from
Northern Norway, we demonstrated decreasing concentrations of many
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legacy POPs from 1979 to 2007 (Nøst et al., 2013). Our results also
suggested that earlier born birth cohorts had higher concentrations of
legacy POPs compared to later born cohorts. Overall, observed time
trends in human biomonitoring studies demonstrate the link with
trends in environmental emissions (the sum of environmental releases
across the chemical life cycle; manufacturing, use and disposal stages)
(Nøst et al., 2017). Indeed, the observed trends for PCBs in blood in the
longitudinal study was in agreement with those predicted by time-
variant mechanistic modeling that was based on historic emissions and
published data on environmental fate and human bioaccumulation
(Nøst et al., 2013, 2017). In summary, changes in human exposure to
POPs across calendar years reflect changes in emissions, environmental
concentrations and dietary intakes.
The interdependence of age, period, and cohort effects produces
mutual confounding in time-trend studies (Glenn, 2003). As age was
confounded by periodic changes in the previous longitudinal study, the
blood POP trends were decreasing as the men aged (Nøst et al., 2013),
which is in apparent contrast to the positive associations observed be-
tween age and concentrations of several legacy POPs in many cross-
sectional studies (e.g. Hardell et al., 2010; Wolff et al., 2005). Thus, in
order to further expand our knowledge of human time trends of POPs
and the relevance of age-period-cohort effects to the interpretation of
human biomonitoring, the present study was based on repeated cross-
sectional samples of 30 year olds in the same population surveys from
Tromsø, Norway as in our previous longitudinal study using repeated
individual measurements. This allowed us to extract information on
changing human concentrations in reproductively active ages while
using repeated cross-sectional sampling from the same population
surveys over a time-period of 22 years. Finally, we aimed to evaluate
the agreement of measured concentrations of PCB-153 and predicted
concentrations from an emission-based mechanistic exposure model as
previously used.
2. Materials and methods
2.1. Study population and subject selection
The basis of this study is repeated population surveys in the muni-
cipality of Tromsø in Northern Norway where over 40,000 people have
participated (summarized by Jacobsen et al., 2012). We used samples
from the surveys conducted in 1986–1987 (hereafter referred to as
1986), 1994–1995 (1994), 2001, and 2007–2008 (2007). For each
survey, 45 subjects at the age of 30 at the time of the survey were
randomly selected (samples from the 2007 survey included 30 and 31
year olds). In total, the present analyses were comprised of 180 serum
samples. Both sexes at the age of 30 were chosen to represent an age
group that is within reproductive ages. Birth year and body mass index
information was extracted from questionnaires.
The study was approved by the Regional Committees for Medical
Research Ethics. Participation was voluntary and all participants pro-
vided informed consent. Serum samples were stored at −70 °C until
they were shipped frozen for analyses.
2.2. Analytical methodology
All POP analyses were performed in 2016 at the Centre de tox-
icologie du Québec (CTQ), Institut National de Santé Publique du
Québec (INSPQ), Québec, Canada. Serum samples were extracted and
analyzed for hexachlorobenzene (HCB); oxy-chlordane; PCB congeners
52, 101, 118, 153, 156, 170, and 180; p,p′-dichlorodiphenyldi-
chloroehylene (p,p′-DDE); p,p′-dichlorophenyltrichloroethane (p,p′-
DDT); β- hexachlorohexane (β-HCH) and trans-nonachlor. In short,
0.5–1mL serum samples were extracted using hexane and saturated
ammonium sulphate solution. The extracts were cleaned up using
Florisil columns before analyzed using gas chromatography coupled to
a mass spectrometer operating in electron capture negative ionization.
Certified reference materials and blank samples were analyzed along
with the samples. The method is described in detail by Fisher et al.
(2016). Mean recoveries of internal standards were 98%, 79%, 114%,
104% for the 1986, 1994, 2001, and 2007 samples, respectively.
2.3. Lipid determinations
Concentrations of total cholesterol (CHOL) and triglycerides (TG)
were available from analyses at the time of blood sampling. The
methods for determination are described by Wilsgaard et al. (2001) for
samples from 1986 and 1994, by Hartz et al. (2004) for samples from
2001, and by Johnsen et al. (2011) for samples from 2007. The con-
centrations were summed according to the formula by Covaci et al.
(2006):
= + +Total lipid(TL) 1.33*TG 1.12*CHOL 1.48(g/L)
2.4. Time-variant model simulations of PCBs in serum
Simulations of lipid-normalized serum concentrations of PCB-153 in
1986, 1994, 2001, and 2007 were carried out using the time-variant
multimedia mechanistic CoZMoMAN model (Breivik et al., 2010). Si-
mulations were performed assuming time-variant emission scenarios
(Quinn et al., 2011). In general, model parameters were set as outlined
by Breivik et al. (2010) and further described in Nøst et al. (2013).
Specifically, trends and concentrations in the environment in Northern
Norway were assumed similar to those of western areas of the Baltic sea
drainage basin, including Sweden and areas in southeastern Norway, as
in the model development. Dietary input parameters were selected as
described for the average Norwegian fish consumption by Nøst et al.
(2013). Model predictions for PCB-153 were obtained for the birth
years 1956, 1964, 1971, and 1977 corresponding to those of the study
participants. All model calculations assumed that fish consumption was
equal among the birth cohorts and two scenarios of fish consumption
were considered. Fish consumption rates were either assumed corre-
sponding to the average Norwegian population or as a category re-
presenting lower consumption than the average as described for this
age group in Norway (Totland et al., 2010). Details of model para-
meterization is presented in Table 1 and further as described by Nøst
et al. (2013).
2.5. Data treatment and statistical analyses
All statistical analyses were conducted using R, version 3.2.1 (R
Foundation for Statistical computing, Vienna, Austria). Statistical sig-
nificance was defined as p < 0.05. All POP results were lipid-adjusted
and values below the limit of detection (LOD) were replaced by the LOD
divided by √2. One sample result was not available due to technical
difficulties. Only max values and the LOD values were presented for
compounds with detection frequencies below 40%. Spearman's ρ values
were calculated for correlations. We used the Wilcoxon rank sum test
(Mann-Whitney U-test) to test differences in POP and lipid concentra-
tions between sampling years and sexes.
3. Results
3.1. Characteristics of study participants and POP concentrations across
surveys
The proportion of men and women was unequally distributed across
the four sampling time points and characteristics of study participants
are presented in Table 2. Lipid concentrations were not significantly
different among sexes (lowest p-value in Wilcox test 0.057). The four-
teen POPs included in the analysis were detected in the majority of
samples with the exception of PCB-52, PCB-101 and p,p′-DDT for
which> 60% of samples were< LOD (detection limits and frequencies
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are presented in Table S1). Lipid-normalized POP concentrations are
summarized in Table 3 and concentrations in ng/mL serum are pro-
vided in Table S2. The POPs detected in highest concentrations were
p,p′-DDE followed by PCB-153 for both sexes throughout the sampling
period (Table 3 and Fig. 1). The median decreases in summed serum
POP concentrations (lipid-adjusted) in 1994, 2001, and 2007 relative to
1986 were − 71%, − 81%, and − 86% for women and − 65%,
− 77%, and − 87% for men, respectively. The differences between
1986 and 1994 were most significant compared to the other con-
secutive pairs of sampling years (Table S3). The average annual de-
creases in medians of summed POP concentrations across the study
period were − 4% for both women and men and substantial declines
were observed for all compounds (absolute and percentage changes
presented in Table S4). Boxplots of concentrations of the two most
prevalent POPs, PCB-153 and p,p′-DDE, are presented in Fig. 2 for men
and women in 1986, 1994, 2001, and 2007.
3.2. Differences between sexes in each sampling year
Concentrations of PCB-153, −156, −170, −180, oxy-chlordane
and trans-nonachlor were higher in men than in women in 1986, 1994
and 2001 (Wilcoxon rank sum test p value<0.05; Table S5) but dif-
ferences were not significant across the same years for the other POPs.
In 2007, there was no sex difference in any POP concentration with the
exception of β-HCH, which was higher among women. When com-
paring concentrations for men to those for nulliparous women in each
sampling year separately, there were fewer compounds with significant
differences in all sampling years and in 2001, only β-HCH and trans-
nonachlor were significant (Table S6). Further, the corresponding
comparisons of concentrations in nulliparous and parous women de-
monstrated that there were significant differences for multiple com-
pounds in several years, especially in 2001 (Table S7), including β-HCH
and trans-nonachlor that were significantly different between nulli-
parous women and men in the same sampling year. Concentrations of
PCB-153 and p,p′-DDE are presented for nulliparous women, parous
women and men separately in Fig. S1.
3.3. Intra-POP correlations across sampling years
The correlations between concentrations (lipid-adjusted) for nine of
eleven well-detected POPs were high (mostly ≥0.5), but varied across
the study period and according to compound (Fig. S2). For many
compounds, the correlations were strongest in 1994 or 2007. For ex-
ample, the correlation of PCB-153 and p,p′-DDE was 0.31, 0.70, 0.63,
0.81, and that of PCB-153 and PCB-180 was 0.88, 0.96, 0.94, 0.88 in
1986, 1994, 2001, and 2007, respectively. The two POPs with lowest
correlation to any other POP were β-HCH and p,p′-DDE.
Table 1
Input information to the CoZMoMAN model calculations. Each line represents one model simulation.





1956 Women 2b 1981c 1984c 6c All combinations specified were run according to two model scenarios for fish
consumptiond:
1964 Women 2b 1989b 1992b 6b 1) Average






a Number of months of breast feeding for each child.
b Median observation of the women in information obtained in questionnaires.
c Assumed similar to the women of the birth year 1964.
d Parameterization of fish consumption is described as the average fish consumption in the general Norwegian population in Nøst et al. (2013) and as ‘less than
average’ consumption. ‘Average fish consumption’ was represented by the scaled consumption rates according to 124 g/day in 2000 and correspondingly for ‘less
than average consumption’ was represented by scaling to 71 g/day in 2000 (Totland et al., 2010). Information on median fish consumption was not available.
Table 2
Descriptive statistics of the randomly chosen 30 year olds in four population
surveys in the Tromsø Study. Numbers in parentheses represent numbers of
subjects (N).
Sampling year 1986 1994 2001 2007








Women (N) 31 28 24 25
Men (N) 14 17 21 20
No. of child
birthsa
0 6 8 15 13
1 10 7 2 4
2 14 9 6 7
3 1 4 1 1
Birthyear children NAb 1984–1995 1990–2001 1995–2007
Median birthyear NAb 1988 1994 2000
Median breastfeeding
months
NAb 6 4 13
Women
Cholesterol
Median 195.7 188.9 186.9 181.8
(mg/dL) Min 141.1 138.8 140.8 73.47
Max 376.3 261.4 245.6 243.6
Triglycerides Median 77.88 85.84 81.42 88.50
(mg/dL) Min 41.59 43.37 38.94 35.40
Max 319.5 434.5 680.6 309.8
Total lipid (g/L) Median 4.65 4.78 4.61 4.61
Min 3.89 3.95 3.68 2.77
Max 8.74 10.2 13.3 7.68
Men Cholesterol Median 224.9 200.7 202.6 175.9
(mg/dL) Min 160.9 114.1 140.0 135.3
Max 275.3 269.5 244.0 255.2
Triglycerides
(mg/dL)
Median 101.3 134.5 131.0 92.92
Min 53.98 45.13 43.37 53.10
Max 226.6 365.5 313.3 416.0
Total lipid (g/L) Median 5.46 5.34 5.33 4.49
Min 4.00 3.36 3.73 4.04
Max 7.38 8.52 8.32 9.83
a For 1986, 1994 and 2001 there were 2, 4, 14 women, respectively, that did
not report any explicit number of children nor any details of any child birth in
the questionnaires. These were assumed not to have children.
b NA=Not available.
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3.4. Predictions of PCB concentrations
Predicted concentrations (ng/g lipid) of PCB-153 were within a
factor of 1.33, 2.57, 3.60, 3.00 of the median concentrations measured
in 1986, 1994, 2001, 2007, respectively, in women and 1.12, 2.10,
2.12, 2.55 in men, if assuming fish consumption in the persons corre-
sponding to the average in the Norwegian population (Fig. 3 and Table
S8). When assuming less than Norwegian average fish consumption, the
predicted concentrations were within a factor of 0.76, 1.85, 2.33, 2.40
of those measured in the same sampling years in women and 0.67, 1.39,
1.55, 1.76 in men, respectively. The decreases in concentrations in PCB-
153 in 1994, 2001, and 2007 compared to 1986 were −60%, −74%,
−82% for median measurements in women and the corresponding
numbers decreases were −4%, −20%, −43% for the predicted con-
centrations. For men, the observed decreases were −55%, −72%,
−84%, and the predicted decreases were -6%, −36%, and −58% in
the respective years.
3.5. Comparing biomonitoring results in the Tromsø Study
Median concentrations of PCB-153 (ng/g lipid) in the 30 year old
men were 61%, 39%, 25%, and 20% in 1986, 1994, 2001, and 2007 of
Table 3
Concentrations (ng/g lipid) of 14 POPs analyzed in serum samples of 30 year olds in four population surveys in the Tromsø Study.
Women 1986 N=31 1994 N=28 2001 N=24 2007 N=24
Median Min Max Median Min Max Median Min Max Median Min Max
PCB-52 – <LOD 1990 – – <LOD – <LOD 300 – – <LOD
PCB-101 – <LOD 1230 – – <LOD – <LOD 40 – – <LOD
PCB-118 31 9 604 9 2 20 9 4 23 5 <LOD 17
PCB-138 101 9 291 40 11 68 21 10 116 18 5 88
PCB-153 165 30 425 65 23 120 43 19 204 30 10 183
PCB-156 14 7 35 4 < LOD 9 4 < LOD 18 3 <LOD 12
PCB-170 35 19 85 14 6 31 9 4 43 7 3 39
PCB-180 94 49 235 46 21 89 25 14 128 19 8 134
HCB 61 28 140 11 4 23 16 9 41 12 5 23
p,p′-DDE 533 28 2340 114 31 295 67 19 1180 46 12 328
p,p′-DDT 23 < LOD 83 – <LOD 16 – <LOD 14 – <LOD 18
β-HCH 25 7 58 4 < LOD 14 5 < LOD 12 3 <LOD 149
oxy-chlordane 9 4 21 3 < LOD 6 3 2 10 2 <LOD 6
trans-nonachlor 15 5 45 7 < LOD 15 7 < LOD 20 4 <LOD 12
Men 1986 N=14 1994 N=17 2001 N=21 2007 N=19
Median Min Max Median Min Max Median Min Max Median Min Max
PCB-52 – <LOD 84 – – <LOD – – <LOD – – <LOD
PCB-101 – <LOD 11 – – <LOD – <LOD 22 – – <LOD
PCB-118 31 15 62 16 7 27 9 6 28 4 2 11
PCB-138 121 68 200 52 30 209 35 20 102 18 8 35
PCB-153 218 119 338 99 61 348 60 38 171 35 19 66
PCB-156 24 16 37 8 5 26 6 2 12 2 <LOD 7
PCB-170 58 32 79 23 16 68 13 9 31 9 4 18
PCB-180 164 95 226 71 46 226 39 24 98 24 13 50
HCB 78 50 152 16 9 33 19 8 46 11 5 18
p,p′-DDE 438 106 718 110 57 366 73 32 1650 39 16 79
p,p′-DDT 19 < LOD 53 – <LOD 19 – <LOD 14 – – <LOD
β-HCH 20 14 53 4 < LOD 8 4 < LOD 32 – <LOD 5
oxy-chlordane 15 6 23 6 2 23 5 2 13 2 <LOD 5
trans-nonachlor 38 11 62 12 4 66 12 5 23 6 <LOD 14
Fig. 1. Relative contributions of individual POPs to their sum (in %) in serum samples from four sampling years (men and women combined). The figure is based on
the most prevalent POPs in lipid weight concentrations as presented in Table 3.
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those in the longitudinal study of older men in the same sampling years
in the Tromsø Study (Fig. 4). Further, the observed relative decreases in
the 30 year old men were −55%, −72%, −84% for 1994, 2001, and
2007 relative to 1986 and the corresponding decreases for the same
sampling years in the older Tromsø men were −31%, −33% and
−53%, respectively. Concentrations in men in this study were very
similar to corresponding results from a previous study including re-
peated cross-sectional samples of pooled blood from Norwegian men in
the age group 40–50 years old (Thomsen et al., 2007). No comparable
study was found that included only women and thus women are not
displayed in Fig. 4. However, the time trend in women in this study was
similar to the trend in men.
4. Discussion
4.1. Changes in POP concentrations in the 30 year olds from 1986 to 2007
This study of serum POP concentrations in repeated cross-sections of
30 year old men and women from Northern Norway adds to the evi-
dence of decreasing environmental and human concentrations of many
legacy POPs in many countries during the study period. All compounds
demonstrated decreasing concentrations across sampling years and the
largest decrease was observed from the first survey in 1986, especially
for HCB and β-HCH. Time trends such as those observed in this study
are compelling results of decreasing concentrations in human exposure
media following strengthened regulation of production and use of these
compounds since the 1970s (Nøst et al., 2017; Bignert et al., 1998;
Hung et al., 2010; Rigét et al., 2010). Our observations could reflect
that the decreases in emissions of POPs studied were possibly largest
early in the sampling period and that the relative decreases differed
across compounds according to differences in emission histories as well
as in environmental and human degradation/elimination rates (Nøst
et al., 2017).
As calculated across the study period, the annual decreases in con-
centrations of all PCBs in the 30 year olds were −4% for both women
and men across the study period and the yearly percentage changes
across the study period were very similar across compounds (Table S4).
The observed decline in this period is steeper compared to observations
for PCBs in pooled blood samples from Norway with overlapping
sampling years (-2.9% during 1977–2003) and less pronounced than an
Fig. 2. Serum concentrations of PCB-153 (upper) and p,p′-DDE (lower) in ng/g lipid weight for 30 year old women and men in Northern Norway in the sampling
years 1986, 1994, 2001, and 2007. Boxes represent the 25th–75th percentiles, horizontal lines represent the median, whiskers indicate 1.5 times the length of the
interquartile range above and below the 75th and 25th percentiles, respectively, and outliers are represented as data points.
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observed decline for PCBs in blood in Sweden (-7.2% during
1993–2007) (Hardell et al., 2010). Although study periods did not
completely overlap, the periodic changes in concentrations between
studies were of the same magnitude. Overall, rates of declines for the
exposures in these study groups in Norway and Sweden were rather
similar and these observations are in accordance with extensive mon-
itoring results demonstrating decreasing concentrations of many legacy
POPs in the environment (Bignert et al., 1998; Hung et al., 2010; Rigét
et al., 2010) and in humans (Hovinga et al., 1992; Høyer et al., 2000;
Tee et al., 2003; Vo et al., 2008; Nøst et al., 2013, 2017; Hardell et al.,
2010) in many countries in the same time period.
Concentrations in the 30 year old women in 2007 were similar to
those in women in Northern Norway in 2007–2008 during and after
their pregnancy (Hansen et al., 2010). Concentrations in the 30 year old
men were similar to those observed in pooled samples of 40–50 year old
men in Norway during 1977–2003 (Thomsen et al., 2007).
The age group of 30 year olds was chosen to obtain relevant bio-
monitoring results that could reflect exposure for reproductively active
ages in the source population. This is relevant with regards to trans-
lating knowledge of changing human exposure into conjectures of
prenatal exposure for the young and future generations. This study has
shown that exposures to legacy POPs for men and women at re-
productive ages in Northern Norway has decreased considerably since
the 1980s. If assuming similar breast-feeding behaviors among women
throughout the same period, early life exposures to the same com-
pounds in the Norwegian population have also been extensively re-
duced during the last decades.
4.2. Comparing biomonitoring results from different study designs
The concentrations of POPs in the 30 year olds were lower in each
sampling year compared to observed concentrations in our previous
longitudinal study of older men from the same population surveys (in
that study, median age increased from 50 to 71 between 1986 and 2007
and ranged 36–61 in 1986). This was expected as cross-sectional bio-
monitoring studies have frequently observed positive associations be-
tween concentrations of many POPs and age (e.g. Hardell et al., 2010;
Wolff et al., 2005) due to higher historic exposure in the older birth
cohorts (Quinn and Wania, 2012). Also, the current study group in-
cluded women that had slightly lower concentrations of POPs which is
likely due to the loss processes related to child birth and breast feeding
(e.g. Hardell et al., 2010; Wolff et al., 2007).
In the present study, the age group was fixed across sampling times
whereas the birth cohorts varied. This study design differed from our
previous longitudinal study using repeated individual measurements
(where birth cohort was fixed and age varied across sampling years)
and provides important information about age-period-cohort effects of
POPs. The inter-individual time trends in 30 year olds in the current
study were more pronounced as compared to the intra-individual time
trends observed in older men in the same geographical region. The
steeper decline in the 30 year olds could reflect birth cohort effects
Fig. 3. Comparing measured concentrations of PCB-153 (ng/g lipid; dots re-
present median and whiskers the lowest and highest measurements) in the four
sampling years to predictions (dashed lines) obtained from the time-variant
CoZMoMAN model. Predictions were obtained based on median descriptive
information from the study participants as described in Table 1 with separate
lines representing predictions for average fish consumption in the Norwegian
population and one category of less than average consumption.
Fig. 4. Comparing the concentrations of PCB-153 (ng/g
lipid) in the two Norwegian repeated cross-sectional (CS)
sampling of 30 year old men (present study) or 40–50 year
old men (Thomsen et al., 2007) and the longitudinal (LT)
study including repeated individual measurements in
older men (median age increased from 43 to 71 between
1979 and 2007 and ranged 29–54 in 1979) (Nøst et al.,
2013).
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related to a relative higher historic exposure in the older age group
(previous longitudinal study). Further, continued exposure to POPs
after decreased environmental emission could also be higher in the
older men compared to the younger study groups related to behavioral
differences, e.g. higher fish consumption in the older group. These
comparisons demonstrated variation in time trends observed within the
same population in the exact same sampling years, which is explained
by differences in study design (selected age group and whether time
trends between individuals or within individuals were assessed).
Nevertheless, both studies provide evidence of declining POP con-
centrations.
Using the design of repeated sampling of a set age group was also
performed in a previous Norwegian study (Thomsen et al., 2007). The
study included pooled blood samples of men in the age group 40–50
years old and the observed concentrations and time trends in that study
were very similar to that in the 30 year olds in Northern Norway
(Fig. 4). Thus, the time trends demonstrated in the three studies tar-
geting time trends using different designs were in overall agreement
and the biomonitoring efforts in these study periods revealed similarly
declining concentrations in adults in Norway. Still, birth cohort effects
were evident and the interpretation of biomonitoring studies must re-
gard historic exposures and birth cohort effects (Nøst et al., 2017;
Quinn and Wania, 2012; Ritter et al., 2009).
4.3. Evaluation of time-variant model estimations
Evaluation of model predictions of human POP concentrations using
comparisons with measurements are important to challenge model
parameterizations of historic emissions and environmental and human
fate to eventually increase credibility in mechanistic models. Models
such as CoZMoMAN can help to increase the mechanistic understanding
of relationships between emissions and environmental and human fate
processes that are hard to deduct from observations alone.
Overall, the slopes in decreasing time trends for PCB-153 estimated
by the CoZMoMAN model (4 time points) were in reasonable agreement
with the observed concentrations (all within factor 3). Median con-
centrations were over-predicted in the last three sampling years and
imply that the model predictions for human exposure media (e.g. es-
timated dietary consumption) was overestimated. Median concentra-
tions were chosen for the observations as most input to the model (not
dietary information) was based on median information from the study
group although mean concentrations measured agreed slightly better
(results not presented). Still, the predicted relative declines were in
overall agreement with those measured, especially in men, and also in
agreement with declines in predicted PCB concentrations in older men
in our previous longitudinal study (Nøst et al., 2013). Of note, a modest
predicted decrease from 1986 to 1994 was also observed in that study.
A smaller range for the parameterized women and men was predicted
for the recent years compared to the earlier years and was likely re-
sulting from more homogenous parameterization of the environmental
exposures and no child births.
Agreement of absolute concentrations was better for 30 year old
men and women when assuming less fish consumed compared to the
Norwegian average. Indeed, lower than average fish consumption is
expected for this age group in Northern Norway and it is lower com-
pared to older age groups (Totland et al., 2010). Thus, it represented
the more realistic scenario of the two regarded, especially for recent
years. Any temporal trend in dietary intakes (e.g. cohort dependent
changes in fish intakes) was not regarded by the model and thus cannot
be disregarded as a source of discrepancy between measured and pre-
dicted concentrations. The better agreement observed for older men
(Nøst et al., 2013) could be due to that they were relatively more ex-
posed from fish consumption and that the main exposure pathway,
represented by fish intake, is better characterized for this study group as
compared to the younger 30 year olds. The predictions were in better
agreement with observations for men as compared to women and likely
reflected the variation introduced when regarding model para-
meterization of child births and related loss processes.
The overall observation is that the concentration trends observed in
human biomonitoring are in accordance with predictions from me-
chanistic modeling as this study was within a factor 3 of measurements.
CoZMoMAN predictions for PCB concentrations (Breivik et al., 2010;
Quinn and Wania, 2012; Nøst et al., 2016) and their temporal changes
(Nøst et al., 2013) have previously demonstrated acceptable perfor-
mance within the ranges of measured concentrations, especially on
group basis as performed in this study. Predictions in individual hu-
mans have also been evaluated against single blood sample measure-
ments (Nøst et al., 2016; Wood et al., 2016; Rylander et al., 2015) and
have shown similar agreement (most predictions within factor 3) as in
this study using group comparisons. Collectively, such studies confirm
the relations between past emissions of POPs and the exposures ex-
perienced by humans (Nøst et al., 2013, 2017; Quinn and Wania, 2012;
Ritter et al., 2009).
4.4. Differences in POP concentrations between sexes
Median concentrations of POPs were higher among men in the first
three sampling surveys but no difference among sexes was evident in
2007, although concentrations were slightly higher for β-HCH in
women. Higher concentrations in men have been observed in other
populations in overlapping study periods and have been largely as-
cribed to differences in body lipid distributions between sexes and ex-
cretion of POPs related to childbirth, especially through breast-feeding,
in women (e.g. Hardell et al., 2010; Wolff et al., 2007). There were few
nulliparous women among the women included in the first two study
years but more in the last sampling years. Thus, it is likely that a
fraction of the difference between sexes in the early sampling years
were augmented due to lowered concentrations in parous women due
to loss related to child birth. Indeed, the sex differences were not as
significant across men and nulliparous women in each year and there
were differences across nulliparous women and parous women, al-
though depended on sampling year and the number of women in each
year was small. Thus, differences between men and women and be-
tween parity groups varied across sampling years and likely reflected
sex differences in exposures and degradation rates and the relative
importance of loss of PCB-153 through birth and breast-feeding ac-
cording to the trends in environmental exposures (Nøst et al., 2016).
Notably, the observed sex differences for concentrations of PCB-153
were reproduced in the model predictions and likely reflects that model
parameterizations adequately captures gender differences in exposure
and overall loss processes.
4.5. Temporal variation in POP composition
Concentrations of p,p′-DDE contributed the most to the summed
POP concentrations in all years but the relative contribution of this
compound to the summed POP concentrations decreased. PCB con-
geners 153, 180, 138 dominated summed PCB concentrations in the
latest three sampling years. The changes in relative composition of
compounds can likely be explained by concurrent processes reflecting
decreased emissions as well as environmental degradation and human
elimination half-lives that both have compound-specific rates. For ex-
ample, the large decreases for p,p′-DDT, β-HCH and HCB between the
first two consecutive sampling years likely reflect less exposure to and
excretion of POPs with shorter half-lives (Woodruff et al., 1994), ren-
dering POPs with longer apparent half-lives, e.g. the higher chlorinated
PCBs (Shirai and Kissel, 1996), with higher relative importance in the
more recent sampling years. Further, control strategies are more effi-
cient at reducing primary emissions of pesticides as compared to PCBs
due to the long half-lives of products containing PCBs (Breivik et al.,
2007) and secondary emissions which also likely influenced the trends
observed across different POPs.
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Correlations between POPs were moderate or strong for most
compounds in all sampling years but no evident trend could be inter-
preted from POP correlations across sampling years. Small differences
in correlations might reflect compound-specific transitions in dom-
inating influence of recent primary emissions to the environment and
recent exposures versus dominating influence of environmental and
human persistence of POPs of past exposures. Still, their consistent
strong correlations implicate similar rates of observed decreases that
again suggest similar declines in trends in production and use (Breivik
et al., 2007; Schenker et al., 2008; Li et al., 2005) as well as environ-
mental and human persistence. Accordingly, dietary patterns have been
associated with blood concentrations of POPs in pregnant women in
Northern Norway (Veyhe et al., 2015) and demonstrate the importance
of this exposure route to women in age ranges that include the 30 year
olds in this study. However, certain POPs, especially β-HCH, were
weakly correlated to the other measured POPs and suggest less similar
rates of concentration declines and/or exposure pathways for certain
POPs.
4.6. Study strengths and limitations
As this study consisted of a limited sample number and included
both men and women (both nulliparous and parous women), a thor-
ough evaluation of all predictive factors could not be performed by
statistical analyses. Especially, the low number of subjects hampered
the assessment of parity among women in each year. Also, individual
dietary information was not available for the model parameterization
and we used estimates of average consumption in Norwegian popula-
tions to reflect the fish consumption in the study population (Nøst et al.,
2013). Further, breast-feeding information was not available for all
women in the first sampling year so we used the median estimates for
the two subsequent sampling years (they were the same). Still, these
assumptions are likely valid.
Sample integrity was considered good based on the results from our
past study where we evaluated the sample integrity by reanalyzing lipid
concentrations. We found very little discrepancy between lipid con-
centrations from the time of blood sampling and those of a reanalysis
for most samples at time of analyses in 2012 (Nøst et al., 2013).
Comparisons between the biomonitoring results in the 30 year olds
and those of the previous study including older men could be somewhat
confounded by laboratory differences as results originated from two
different laboratories. Still, both studies have meet the QA-QC criteria
for the sample preparations and the laboratories both perform well in
the interlaboratory study in the Arctic Monitoring and Assessment
Programme ring test system (organized by the Centre de toxicologie du
Québec of the Institut national de santé publique du Québec (2013)).
Future monitoring studies should include more recent samples and
expand the selection of compounds to include both established POPs as
well as other compounds of increasing concern where human exposure
has been recent or current.
4.7. Summary of key findings
Declines in serum concentrations from 1986 to 2007 were sub-
stantial for legacy POPs in men and women at reproductive ages in
Northern Norway and are generally consistent with previous long-
itudinal biomonitoring results in the study population. Especially, men
and women of reproductive age had lower concentrations and more
pronounced declines compared to older and aging men. The measured
concentrations and observed declines likely reflect a combination of
recent and historic exposures. The small differences in trends observed
could thus be attributed to different study designs, i.e. the age group,
gender and cross-sectional vs longitudinal design.
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